The Quality End-of-Life
Care Coalition of Canada (QELCCC) has given their second annual Award of
Excellence in Advocacy to Russell Williams, President of Canada’s
Research-Based Pharmaceutical Companies (Rx&D).
Russell has worked tirelessly as an advocate for hospice palliative care, from
his involvement in establishing the West Island Palliative Care Residence to
his advocacy efforts as a member of the Champions Council of the Canadian
Hospice Palliative Care Association (CHPCA).
“Russell has contributed a great deal to the national and provincial
discussions around palliative care, and for that we are truly grateful. We are
very proud to have such a champion advocating for our cause,” stated Sharon
Baxter, secretariat of the QELCCC and Executive Director of the Canadian
Hospice Palliative Care Association.
Before joining Rx&D, Mr. Williams had a successful career in provincial
politics and community service. For fifteen years, he represented the Montreal
riding of Nelligan in the National Assembly of Quebec. He is well known for his
dedication and perseverance as an advocate for individual rights and government
services focused on the needs of its citizens. He continues active volunteer
involvement in palliative care.
“I am so honoured to have been considered for this award. The QELCCC is an
impressive group and I am proud to have worked closely with both them and the
Parliamentary Committee on Palliative and Compassionate Care to advance this
issue at the national level. Together I believe we can improve access to
palliative care while encouraging Canadians to plan for the end of life,”
stated Mr. Williams.